Lund, Sweden

Sal O Gronowitz

This inventor holds 1 USPTO granted patent. Top assignee: Medivir Ab. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sal O Gronowitz. Retrieved from https://idiyas.com/inventor/sal-o-gronowitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sal O Gronowitz: Innovator in Pharmaceutical Compounds

Introduction

Sal O Gronowitz is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can be used for therapeutic treatments.

Latest Patents

Sal O Gronowitz holds a patent for "5-substituted pyrimidine nucleosides and nucleotides." This invention is directed to compounds of a specific formula, wherein various substituents are defined to enhance their therapeutic efficacy. The compounds can be utilized in pharmaceutical compositions aimed at treating viral infections.

Career Highlights

Sal O Gronowitz is associated with Medivir AB, a company known for its focus on developing innovative antiviral therapies. His work has contributed to the advancement of medical science, particularly in the area of viral treatment.

Collaborations

Sal has collaborated with notable colleagues such as Karl N Johansson and Hans C Malmberg, further enhancing the impact of his work in the pharmaceutical industry.

Conclusion

Sal O Gronowitz is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly impact therapeutic treatments for viral infections. His contributions continue to be recognized in the field of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…